An adaptive enrichment design using Bayesian model averaging for selection and threshold-identification of predictive variables
Biometrics · 2024
DOI: 10.1093/biomtc/ujae141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, 2024. Verfasst von Lara Maleyeff und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, QC H3A 1G1, Canada. Hauptthemen laut MEDLINE: Bayes Theorem, Biomarkers, Computer Simulation, Models, Statistical. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Fonds de Recherche du Québec, Nature et Technologies, Natural Sciences and Engineering Council of Canada.
Abstract (Originalsprache)
Precision medicine is transforming healthcare by offering tailored treatments that enhance patient outcomes and reduce costs. As our understanding of complex diseases improves, clinical trials increasingly aim to detect subgroups of patients with enhanced treatment effects. Biomarker-driven adaptive enrichment designs, which initially enroll a broad population and later restrict to treatment-sensitive patients, are gaining popularity. However, current practice often assumes either pre-trial knowledge of biomarkers or a simple, linear relationship between continuous markers and treatment effectiveness. Motivated by a trial studying rheumatoid arthritis treatment, we propose a Bayesian adaptive enrichment design to identify predictive variables from a larger set of candidate biomarkers. Our approach uses a flexible modeling framework where the effects of continuous biomarkers are represented using free knot B-splines. We then estimate key parameters by marginalizing over all possible variable combinations using Bayesian model averaging. At interim analyses, we assess whether a biomarker-defined subgroup has enhanced or reduced treatment effects, allowing for early termination for efficacy or futility and restricting future enrollment to treatment-sensitive patients. We consider both pre-categorized and continuous biomarkers, the latter potentially having complex, nonlinear relationships to the outcome and treatment effect. Through simulations, we derive the operating characteristics of our design and compare its performance to existing methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, QC H3A 1G1, Canada.
- Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada.
- Jewish General Hospital and Lady Davis Institute for Medical Research, Montréal, QC H3T 1E2, Canada.
ORCID-Profile: Lara Maleyeff, Shirin Golchi, Erica E M Moodie
Förderung
- NIH HHS
- Fonds de Recherche du Québec, Nature et Technologies
- Natural Sciences and Engineering Council of Canada
- Canadian Statistical Sciences Institute
- NIMH NIH HHS
- National Institutes of Health
Zitieren
APA
Maleyeff, L., Golchi, S., Moodie, E. E. M., & Hudson, M. (2024). An adaptive enrichment design using Bayesian model averaging for selection and threshold-identification of predictive variables. Biometrics. https://doi.org/10.1093/biomtc/ujae141
Vancouver
Maleyeff L, Golchi S, Moodie EEM, Hudson M. An adaptive enrichment design using Bayesian model averaging for selection and threshold-identification of predictive variables. Biometrics. 2024. doi:10.1093/biomtc/ujae141
BibTeX
@article{Maleyeff2024,
author = {Maleyeff, Lara and Golchi, Shirin and Moodie, Erica E M and Hudson, Marie},
title = {An adaptive enrichment design using Bayesian model averaging for selection and threshold-identification of predictive variables},
journal = {Biometrics},
year = {2024},
doi = {10.1093/biomtc/ujae141}
}
EUVIMED